学术周报 · IF≥10 或专科旗舰刊

眼科领域文献阅读汇编

2026年第47周 (2026-11-20) | PubMed (NLM) · DeepSeek 中英双语
数据来源: PubMed E-utilities · 影响因子筛选: IF≥10 或专科旗舰刊 · 完整摘要不截断
收录论文
13
临床研究
6
基础研究
7
IF≥20
1
IF 10-20
9
子领域
6
期刊种类
10
数据日期
2026-11-20

★本周 Top 10 高影响力文献

#论文期刊IF
1Magnetic induction heating: where will the field go next?Chemical Society reviewsIF 48.3
2Engineered compact TnpB epigenetic editors prevent choroidal neovascularization via Vegfa repression...Protein & cellIF 18.2
3Retinopathy of prematurity: causes, treatment and prevention.Progress in retinal and eye researchIF 16.2
4The functional significance of human macular pigment: Optical, visual and neural effects.Progress in retinal and eye researchIF 16.2
5Confocal microscopy segmentation via prototype-driven semi-supervised learning.Medical image analysisIF 14.0
6Maltodextrin-shielded pumpkin seed protein nanoparticles formed by Maillard-induced protein modifica...Carbohydrate polymersIF 13.2
7Dual-Mechanism Suppression of Posterior Capsule Opacification by an MMP2/9-Responsive Sulforaphane-E...Advanced healthcare materialsIF 11.0
8Risk factors associated with ocular hypertension after steroid use in children.OphthalmologyIF 10.9
9Deepening insights into the interaction between acidic water and pyrite enriched waste rocks.Journal of hazardous materialsIF 10.6
10Low-Concentration Atropine Eye Drops in Children With Myopia and Intermittent Exotropia: The AMIXT2 ...JAMA ophthalmologyIF 10.5

Ŧ期刊分布统计

期刊篇数IF
American journal of ophthalmology3IF 4.7
Progress in retinal and eye research2IF 16.2
JAMA ophthalmology1IF 10.5
Medical image analysis1IF 14.0
Chemical Society reviews1IF 48.3
Advanced healthcare materials1IF 11.0
Carbohydrate polymers1IF 13.2
Ophthalmology1IF 10.9
Journal of hazardous materials1IF 10.6
Protein & cell1IF 18.2

1小儿眼科与斜视 (4篇)

临床研究 (3篇)

JAMA ophthalmology IF 10.5 2026-11-19 PMID: 43056108
The optimal atropine concentration for myopia control in children with coexisting intermittent exotropia (IXT) remains uncertain. To compare the efficacy and safety of 0.01%, 0.02%, and 0.04% atropine eye drops in children with myopia and IXT. This single-center, double-masked, 3-arm randomized clinical trial was conducted from September 2023 to March 2026. Children aged 6 to 12 years with basic-type IXT and myopia (cycloplegic spherical equivalent [SE], -0.50 to -6.00 diopters [D]) were enrolled. Data analysis was conducted from March 2026 to July 2026. Participants were randomized 1:1:1 to 0.01%, 0.02%, or 0.04% atropine eye drops nightly in both eyes. The primary outcome was 12-month change in cycloplegic SE. Secondary outcomes included changes in axial length (AL), exotropia conditions, binocular vision, and ocular safety parameters. Among 264 randomized children (mean [SD] age, 8.4 [1.5] years; 130 female [49.2%]), 224 (84.8%) completed the 12-month assessment. Mean (SD) SE changes were -0.43 (0.50) D, -0.35 (0.51) D, and -0.18 (0.60) D with 0.01%, 0.02%, and 0.04% atropine, respectively (overall P = .001). Compared with 0.01% and 0.02% atropine, 0.04% atropine was associated with less SE progression (vs 0.01%: difference, 0.24 D; 95% CI, 0.11-0.37 D; P < .001; vs 0.02%: difference, 0.16 D; 95% CI, 0.04-0.29 D; P = .02). Mean (SD) AL changes were 0.31 (0.25) mm, 0.25 (0.23) mm, and 0.15 (0.29) mm, respectively (overall P < .001); corresponding differences for 0.04% vs 0.01% and 0.02% were -0.16 mm (95% CI, -0.22 to -0.10 mm; P < .001) and -0.10 mm (95% CI, -0.16 to -0.04 mm; P < .001). Mean (SD) near exodeviation decreased by 3.46 (5.76) prism diopters (PD), 4.84 (8.05) PD, and 6.13 (7.11) PD, respectively (overall P = .04); the reduction was greater with 0.04% vs 0.01% atropine (difference, -2.68 PD; 95% CI, -4.78 to -0.57 PD; P = .008). Study drug-related photophobia occurred in 8 (9.1%), 9 (10.2%), and 19 participants (21.6%) in the 0.01%, 0.02%, and 0.04% atropine groups, respectively; no participant discontinued treatment because of photophobia. In the AMIXT2 randomized clinical trial among children with myopia and IXT, 0.04% atropine eye drops were associated with less myopia progression and axial elongation over 12 months than 0.01% or 0.02% atropine eye drops. Higher concentrations were associated with greater reductions in near magnitude of exodeviation, which warrant further investigation. chictr.org.cn Identifier: ChiCTR2300075312.
中文摘要:合并间歇性外斜视(IXT)儿童近视控制的最佳阿托品浓度尚不明确。本研究旨在比较0.01%、0.02%和0.04%阿托品滴眼液在伴有近视和IXT儿童中的疗效与安全性。该单中心、双盲、三臂随机临床试验于2023年9月至2026年3月开展,数据于2026年3月至7月进行分析。纳入年龄6至12岁、患有基本型IXT和近视(睫状肌麻痹下等效球镜[SE]为-0.50至-6.00屈光度[D])的儿童。受试者按1:1:1比例随机分配每晚双眼使用0.01%、0.02%或0.04%阿托品滴眼液。主要结局为12个月睫状肌麻痹SE的变化。次要结局包括眼轴长度(AL)、外斜视状况、双眼视觉及眼部安全参数的变化。在264名随机入组的儿童中(平均年龄8.4岁,标准差1.5;女性130名[49.2%]),224名(84.8%)完成了12个月评估。0.01%、0.02%和0.04%阿托品的SE变化均值分别为-0.43(0.50)D、-0.35(0.51)D和-0.18(0.60)D(总体P=0.001)。与0.01%和0.02%阿托品相比,0.04%阿托品与更少的SE进展相关(vs 0.01%:差异0.24 D;95% CI, 0.11-0.37 D;P<0.001;vs 0.02%:差异0.16 D;95% CI, 0.04-0.29 D;P=0.02)。AL变化均值分别为0.31(0.25)mm、0.25(0.23)mm和0.15(0.29)mm(总体P<0.001);0.04%与0.01%及0.02%的差异分别为-0.16 mm(95% CI, -0.22至-0.10 mm;P<0.001)和-0.10 mm(95% CI, -0.16至-0.04 mm;P<0.001)。近处外斜度减少均值分别为3.46(5.76)棱镜度(PD)、4.84(8.05)PD和6.13(7.11)PD(总体P=0.04);与0.01%阿托品相比,0.04%的减少幅度更大(差异-2.68 PD;95% CI, -4.78至-0.57 PD;P=0.008)。0.01%、0.02%和0.04%阿托品组分别有8(9.1%)、9(10.2%)和19名受试者出现研究药物相关的畏光;无受试者因畏光停药。在AMIXT2随机临床试验中,与0.01%或0.02%阿托品滴眼液相比,0.04%阿托品滴眼液在12个月内与更少的近视进展和眼轴延长相关。较高浓度与近处外斜度幅度更大程度的减少相关,值得进一步研究。chictr.org.cn 注册号:ChiCTR2300075312。
Progress in retinal and eye research IF 16.2 2026-11-18 PMID: 43051313
Retinopathy of prematurity (ROP) is initiated at preterm birth. Vascular growth in the immature retina, conditioned to low intrauterine oxygen levels, is disrupted by rapid increases in oxygen which suppress oxygen-regulated growth factors. Maternally sourced essential lipids (ω-3 and ω-6 polyunsaturated fatty acids) and insulin-like growth factor-1 are also lost. Later, maturing (but avascular) retina becomes hypoxic and nutrient starved, driving a growth factor surge often causing destructive neovascularization. Current treatments address late-stage neovascular ROP by suppressing elevated vascular endothelial growth factor levels. Recent clinical studies address the initiating events, lack of specific maternally sourced lipids and growth factors, hyperoxia-induced metabolic changes, which induce suppression of normal retinal vascularization and retinal neural maturation. Early enteral supplementation with ω-3 and ω-6 polyunsaturated fatty acids reduces risk of neovascularization. Timed topical corticosteroids during early ROP which alter metabolism to promote normal vessel growth, show great promise in preventing severe disease. Risk algorithms with near 100% sensitivity and high specificity can reduce the number of screening examinations. AI-augmented photography and ultrawide field optical coherence tomography may further refine prediction, diagnosis and treatment. This review synthesizes recent clinical paradigm shifts toward early disease prevention, highlighting how novel metabolic, pharmacological, and digital health strategies can prevent ROP-related vision loss.
中文摘要:早产儿视网膜病变(ROP)始于早产。在子宫内低氧环境下发育的未成熟视网膜血管生长,因出生后氧气快速升高而抑制了氧调节的生长因子,导致血管生成受阻。同时,母体来源的关键脂质(ω-3和ω-6多不饱和脂肪酸)及胰岛素样生长因子-1也发生缺失。随后,逐渐成熟但无血管的视网膜陷入缺氧和营养匮乏状态,驱动生长因子激增,常导致破坏性新生血管形成。目前的治疗主要针对晚期新生血管性ROP,通过抑制升高的血管内皮生长因子水平来发挥作用。近期临床研究关注起始事件、特定母体来源脂质和生长因子的缺乏、高氧诱导的代谢变化,这些因素会抑制正常的视网膜血管化和视网膜神经成熟。早期肠内补充ω-3和ω-6多不饱和脂肪酸可降低新生血管形成的风险。在ROP早期使用定时局部皮质类固醇以改变代谢并促进正常血管生长,显示出预防严重疾病的巨大潜力。敏感性接近100%且特异性较高的风险算法可减少筛查检查次数。人工智能辅助摄影和超广角光学相干断层扫描可能进一步细化预测、诊断和治疗。本综述综合了近期向早期疾病预防转变的临床范式,强调了新型代谢、药理学和数字健康策略如何预防ROP相关的视力丧失。
American journal of ophthalmology IF 4.7 2026-11-17 PMID: 43044711
To evaluate the effectiveness, patient satisfaction, and estimated travel burden reduction associated with telemedicine post-operative week one (POW1) follow-up after strabismus surgery. Retrospective observational case series. A total of 201 patients (age range, 2-83 years of age) who underwent strabismus surgery at a single tertiary academic center between March 2020 and February 2026 and completed an electronic POW1 questionnaire. Patients selected for telemedicine follow-up completed an electronic questionnaire assessing postoperative well-being, diplopia status, and medication adherence, and uploaded ocular photographs for subsequent clinician review. A subset of patients completed a telephone satisfaction survey assessing usability and overall experience. Patient-reported postoperative well-being, diplopia status, medication adherence, post-operative complications, patient satisfaction, and estimated travel avoidance. Of 201 patients, 183 completed telemedicine follow-up without an in-person POW1 visit. Overall, 98.4% reported feeling well postoperatively, 66.7% reported complete resolution of diplopia, and 90.7% reported adherence to prescribed medications. Common free-text response themes included reassurance with recovery, expected postoperative symptoms, visual concerns, and questions regarding postoperative care. Twenty-eight patients completed a satisfaction survey, demonstrating high ratings for ease of use, comfort with the platform, and willingness to use the process again. All respondents agreed that telemedicine follow-up saved time compared with a traditional in-person visit. Telemedicine follow-up was associated with an estimated potential travel reduction of 46,249 miles (mean, 252.7 miles per patient). No postoperative complications were identified among patients managed exclusively through telemedicine follow-up. Telemedicine POW1 follow-up was feasible in selected strabismus patients, with high satisfaction among telephone survey respondents and substantial estimated potential travel avoidance. These findings support further evaluation of telemedicine follow-up as an alternative to routine in-person POW1 visits in appropriately selected patients.
中文摘要:评估远程医疗术后一周随访在斜视手术后的有效性、患者满意度及估计的旅行负担减少情况。这是一项回顾性观察病例系列研究。共纳入201名年龄在2至83岁之间、于2020年3月至2026年2月期间在单一三级学术中心接受斜视手术并完成了电子术后一周问卷的患者。被选为远程医疗随访的患者完成了评估术后健康状况、复视状态和用药依从性的电子问卷,并上传了眼部照片供临床医生后续审查。部分患者完成了电话满意度调查,评估可用性和整体体验。报告了患者的术后健康状况、复视状态、用药依从性、术后并发症、患者满意度和估计的旅行避免情况。在201名患者中,有183名通过远程医疗随访完成了术后一周的随访,无需亲自就诊。总体而言,98.4%的患者表示术后感觉良好,66.7%的患者报告复视完全缓解,90.7%的患者报告遵守了处方药物的服用。常见的自由文本回复主题包括对恢复过程的安心、预期的术后症状、视觉担忧以及关于术后护理的问题。28名患者完成了满意度调查,显示对易用性、对平台的舒适度以及再次使用该流程的意愿评分较高。所有受访者均同意远程医疗随访比传统的亲自就诊节省了时间。远程医疗随访估计可减少46,249英里的潜在旅行距离(人均252.7英里)。在仅通过远程医疗随访管理的患者中未发现术后并发症。远程医疗术后一周随访在选定的斜视患者中是可行的,电话调查受访者满意度高,且估计的潜在旅行避免量显著。这些发现支持在适当选择的患者中将远程医疗随访作为常规术后一周亲自就诊的替代方案进行进一步评估。

基础研究 (1篇)

Chemical Society reviews IF 48.3 2026-11-16 PMID: 42873536
Under the broader concept of magnetic induction (MI), in which magnetic fields are used to induce a current in conductors, magnetic induction heating (MIH) is known in oncotherapy for tumour ablation in what is called magnetic hyperthermia. However, a multitude of wider applications of MIH are beginning to shape opportunities at the interface of materials fabrication. This includes organic and inorganic synthesis, a comprehensive spectrum of biomedical needs, sensing, diagnostics, industrial processing, sustainable technologies, power generation and locomotion. A comparative analysis of reported MI studies is given grouped by application type, providing insight into the different materials employed and temperatures achieved. While MIH is predominantly based on magnetic materials that dissipate energy through hysteresis and Néel/Brownian relaxation losses, electrically conductive materials can also generate heat via eddy-current-induced Joule heating, although they remain relatively underexplored in biomedical applications. We examine the field parameters, the set-ups used and experimental configurations to provide a clear overview of the current landscape. In chemistry these applications will interest researchers in areas such as materials synthesis, electrocatalysis and sustainable chemistry. In the biomedical landscape, we explore studies from neuropathology to endometriosis and ocular disease, and even dental applications. Thus, we enable both specialists and researchers from adjacent fields to contribute with fresh perspectives. This review examines MIH through a new lens, highlighting underrepresented and recent developments and identifying promising directions to accelerate progress across different areas of science.
中文摘要:在磁感应这一更广泛的概念下,即利用磁场在导体中感应电流,磁感应加热(MIH)在肿瘤治疗中以磁热疗的形式用于肿瘤消融。然而,MIH的多种更广泛应用正在材料制造界面塑造机遇。这包括有机和无机合成、广泛的生物医学需求、传感、诊断、工业加工、可持续技术、发电和运动。本文按应用类型对已报告的MIH研究进行了比较分析,提供了对不同所用材料和所达温度的见解。虽然MIH主要基于通过磁滞和Néel/布朗弛豫损耗耗散能量的磁性材料,但电导材料也可以通过涡流引起的焦耳热产生热量,尽管它们在生物医学应用中仍相对未被充分探索。我们考察了场参数、使用的装置和实验配置,以提供当前格局的清晰概览。在化学领域,这些应用将吸引材料合成、电催化和可持续化学等领域的研究人员。在生物医学领域,我们探讨了从神经病理学到子宫内膜异位症和眼部疾病的研究,甚至包括牙科应用。因此,我们使专科医生和来自相邻领域的研究人员能够贡献新的视角。本综述通过新视角审视MIH,强调代表性不足和最新进展,并确定有希望的方向以加速不同科学领域的进步。

2视网膜疾病 (4篇)

临床研究 (1篇)

American journal of ophthalmology IF 4.7 2026-11-18 PMID: 43051311
To assess the correlation between kinetic and static perimetry measurements in patients with retinitis pigmentosa and to develop thresholds that translate 1) mean retinal sensitivity (MRS) from static perimetry and 2) Visual field (VF) area from kinetic perimetry, into kinetic perimetry-derived VF diameter using the International Council of Ophthalmology (ICO) Visual Standards classification of vision loss severity. Retrospective cross-sectional study. Data were obtained from charts of 100 adults with retinitis pigmentosa who had undergone full-field static and kinetic perimetry within a 30-day interval during routine practice at Casey Eye Institute, Oregon Health & Science University, US. Full-field static and kinetic perimetry using the Octopus 900 perimetry device. Static perimetry full MRS and kinetic perimetry VF area cut-off values were derived from Receiver Operating Characteristic (ROC) analysis by mapping the ICO kinetic perimetry VF diameter cut-offs to classify patients into vision loss severity groups. Youden Index and Area Under the Curve were used to determine optimal cutoff values that maximized diagnostic performance. Weighted Kappa statistics assessed the level of agreement between the derived severity classifications, and the ICO VF diameter classification standards. Among the 100 patients, median age was 48.5 years, disease onset at median 28 years, 52% male, 16% with XLRP. MRS correlated strongly with kinetic VF diameter (Spearman's rho 0.83) and with kinetic VF area (rho 0.81); diameter and area were correlated at rho 0.94. ROC analysis derived MRS (dB) cut-offs for vision loss severity were: ≥7.4=mild, 5.3- <7.4=moderate, 3.2- <5.3=severe, 0.6- <3.2=profound, and <0.6=near-blindness/blindness (weighted Kappa coefficient 0.59). Optimal VF area (deg2) cutoffs for distinguishing severity levels were ≥5706=mild impairment, 410 - <5706=moderate, 688- <4100= severe, 71 -<688=profound, <71=near-blindness/blindness (weighted Kappa coefficient 0.73). Strong correlations between MRS and VF diameter measures support the feasibility of mapping static perimetry to kinetic VF diameter ICO standard to classify vision loss severity. This study addresses a critical gap in interpreting retinitis pigmentosa research findings in visual field loss assessment.
中文摘要:评估视网膜色素变性患者动能与静视野计测量值之间的相关性,并开发阈值,将1) 静视野计的平均视网膜敏感度(MRS)和2) 动能视野计的视野(VF)面积转换为基于国际眼科理事会(ICO)视力丧失严重程度分类的动能视野计衍生的VF直径。这是一项回顾性横断面研究。数据来源于美国俄勒冈健康与科学大学凯西眼科研究所常规诊疗中100名接受过30天内全静和全动视野计检查的成年视网膜色素变性患者病历。使用Octopus 900视野计进行全静和全动视野计检查。通过ROC分析,将ICO动能视野计VF直径截断值映射到视力丧失严重程度组,从而得出静视野计全MRS和动视野计VF面积的截断值。使用Youden指数和曲线下面积确定最大化诊断性能的最佳截断值。加权Kappa统计量评估了推导出的严重程度分类与ICO VF直径分类标准之间的一致性水平。在100名患者中,中位年龄为48.5岁,疾病发病中位年龄为28岁,男性占52%,16%患有XLRP。MRS与动能VF直径(Spearman's rho 0.83)和动能VF面积(rho 0.81)呈强相关;直径和面积的相关系数为rho 0.94。ROC分析得出的视力丧失严重程度MRS(dB)截断值为:≥7.4=轻度,5.3- <7.4=中度,3.2- <5.3=重度,0.6- <3.2=极重度,<0.6=接近失明/失明(加权Kappa系数0.59)。区分严重程度水平的最佳VF面积(deg2)截断值为:≥5706=轻度损害,410 - <5706=中度,688- <4100=重度,71 -<688=极重度,<71=接近失明/失明(加权Kappa系数0.73)。MRS与VF直径测量值之间的强相关性支持将静视野计映射到动能VF直径ICO标准以分类视力丧失严重程度的可行性。本研究解决了视网膜色素变性研究结果在视野丧失评估中解释方面的关键空白。

基础研究 (3篇)

Journal of hazardous materials IF 10.6 2026-11-13 PMID: 43044558
The exposure of pyrite enriched waste rocks (PWR) to acidic water can result in acid mine drainage (AMD) generation. Therefore, this study revealed acidic water - PWR interaction mechanism, combining with ion concentration variation and multidisciplinary characterization. The results demonstrated that Fe(III) (1638.5 mg/L), Fetotal (2485.8 mg/L) and SO42- (5649.2 mg/L) concentrations were found to be greatest in static (ST), oscillation (OT) and freeze-thaw (FT) treatment, respectively. The surface roughness of pyrite decreased in OT treatment, while that increased in OT and FT treatment. Compared with original pyrite, the characteristic peaks of SO42- and Fe(III)-sulfate disappeared and the peak intensity of S-O stretching vibration decreased in ST, OT and FT treatments. FeOOH were found in ST treatment, while FeOOH and Fe3O4 were present in FT treatment. These results indicated that Fe oxide passivation layers formed from the static interaction between acidic water and PWR. Surface oxidation products shed from the dynamic interaction between acidic water and PWR. Crucially, the oxidation transformation of Fe(II) to Fe(III) were restricted under periodical temperature difference effects, ultimately resulting in crystalline Fe3O4 formation. This work would provide the scientific reference for the safe disposal and risk management of PWR in mining areas.
中文摘要:含黄铁矿废石暴露于酸性水中可导致酸性矿山排水的产生。因此,本研究结合离子浓度变化和多学科表征,揭示了酸性水与含黄铁矿废石的相互作用机制。结果表明,静态、振荡和冻融处理中Fe(III)、总铁和硫酸根离子的浓度分别最高。在振荡处理中黄铁矿表面粗糙度降低,而在振荡和冻融处理中表面粗糙度增加。与原黄铁矿相比,三种处理后SO42-和Fe(III)-硫酸盐的特征峰消失且S-O伸缩振动峰强度降低。静态处理中发现FeOOH,而冻融处理中存在FeOOH和Fe3O4。结果表明,酸性水与废石的静态相互作用形成了氧化铁钝化层,而动态相互作用导致表面氧化产物脱落。关键的是,周期性温差效应限制了Fe(II)向Fe(III)的氧化转化,最终形成结晶态Fe3O4。该工作为矿区废石的安全处置和风险管理提供了科学参考。
Progress in retinal and eye research IF 16.2 2026-11-13 PMID: 43025584
The foveal region of primates is specialized to accumulate dietary yellow carotenoids, lutein (L) and zeaxanthin (Z) which collectively form the macular pigment (MP). These pigments selectively attenuate short-wave visible light. Although MP is often regarded mostly for its protective role in reducing photo-oxidative damage to the retina, its functional significance to everyday vision is becoming increasingly apparent. Psychophysical methods have been used for decades to measure the pigments showing direct connections to visual function. Evidence is accumulating, however, that the optical effects of MP alter perception under natural viewing conditions. For instance, increasing MP density through intervention enhances chromatic contrast, improves target visibility through simulated atmospheric blue haze, reduces glare disability and discomfort, and speeds recovery from photostress. Conversely, evidence that these optical filtering properties improve conventional visual acuity or contrast sensitivity by reducing chromatic aberration remains limited. Beyond these optical mechanisms, L and Z may also exert biochemical and cellular effects. L and Z accumulate in central nervous system tissue, where intervention studies suggest potential effects on visual processing speed, attention, memory, and neural efficiency. Emerging evidence also supports localized and systemic roles for these carotenoids in retinal development and structure and metabolic regulation. MP density varies by more than an order of magnitude among healthy individuals; while this implies corresponding individual variation in optical filtering, further research is required to determine if this variation extends proportionally to the wider structural, functional, and metabolic effects of these carotenoids.
中文摘要:灵长类动物的中央凹区域专门积累膳食来源的黄色类胡萝卜素叶黄素(L)和玉米黄质(Z),二者共同形成黄斑色素(MP)。这些色素选择性衰减短波可见光。尽管 MP 常被认为主要具有减少视网膜光氧化损伤的保护作用,但其对日常视觉的功能意义日益显现。数十年来,心理物理学方法被用于测量与视觉功能直接相关的色素。然而,证据表明 MP 的光学效应在自然观看条件下会改变感知。例如,通过干预增加 MP 密度可增强色觉对比度,透过模拟的大气蓝雾提高目标可见性,减少眩光致残性和不适感,并加快从光应激中的恢复速度。相反,关于这些光学滤波特性通过减少色差来提高常规视力或对比敏感性的证据仍然有限。除了这些光学机制外,L 和 Z 还可能发挥生化和细胞效应。L 和 Z 在中枢神经系统组织中积累,干预研究表明其对视觉处理速度、注意力、记忆力和神经效率具有潜在影响。新兴证据也支持这些类胡萝卜素在视网膜发育、结构以及代谢调节中的局部和全身作用。健康个体间的 MP 密度差异超过一个数量级;虽然这暗示了光学滤波方面的个体差异,但仍需进一步研究以确定这种差异是否按比例扩展到这些类胡萝卜素的更广泛的结构、功能和代谢效应。
Protein & cell IF 18.2 2026-11-13 PMID: 43021643
Epigenetic editing enables programmable and heritable gene regulation without altering DNA sequence, yet existing platforms remain constrained by large size, cumbersome target design, and limited applicability. Here we engineered catalytically inactive ISDge10 and ISAam1 TnpB systems and developed highly compact RNA-guided epigenetic editors compatible with single adeno-associated virus (AAV) delivery for either transcriptional activation or repression. Activators based on these TnpBs (Dge10on and Aam1on) efficiently activated diverse endogenous genes in vitro, and AAV9-delivered Aam1on achieved robust pancreatic and duodenal homeobox 1 (Pdx1) activation in vivo. For gene repression, by screening 248 human Krüppel-associated box (KRAB) domains with verified effector activity, we identified the most potent effector domain for each TnpB system, resulting in the optimization of Dge10off and Aam1off. These epigenetic editors mediated durable transcriptional repression across multiple loci in diverse cell types. In a mouse model, single-AAV delivery of these editors efficiently suppressed vascular endothelial growth factor A (Vegfa) expression with no detectable activation of DNA damage response markers (γH2AX and p53), resulting in marked reductions in choroidal neovascularization area. Our study expands the epigenetic editing toolbox and provides a potentially safe and durable single-administration therapeutic strategy for wet age-related macular degeneration (wAMD).
中文摘要:表观遗传编辑可实现可编程且可遗传的基因调控而不改变DNA序列,但现有平台仍受限于体积庞大、靶点设计繁琐及适用性有限。本研究工程化改造了催化失活的ISDge10和ISAam1 TnpB系统,开发了高度紧凑的RNA引导表观遗传编辑器,兼容单腺相关病毒(AAV)递送,用于转录激活或抑制。基于这些TnpB构建的激活剂(Dge10on和Aam1on)在体外高效激活多种内源基因,且AAV9递送的Aam1on在体内实现了胰腺十二指肠同源盒1(Pdx1)的强效激活。针对基因抑制,通过筛选248个人类Krüppel相关盒(KRAB)结构域并验证其效应活性,我们确定了每种TnpB系统最有效的效应结构域,从而优化了Dge10off和Aam1off。这些表观遗传编辑器在多种细胞类型的多个位点介导了持久的转录抑制。在小鼠模型中,单次AAV递送这些编辑器有效抑制血管内皮生长因子A(Vegfa)表达,且未检测到DNA损伤反应标志物(γH2AX和p53)的激活,从而显著减少脉络膜新生血管面积。本研究扩展了表观遗传编辑工具箱,并为湿性年龄相关性黄斑变性(wAMD)提供了一种潜在安全且持久的单次给药治疗策略。

3青光眼 (2篇)

临床研究 (2篇)

American journal of ophthalmology IF 4.7 2026-11-16 PMID: 43039286
To examine the association of home and workplace secondhand smoke (SHS) exposure with circumpapillary retinal nerve fiber layer (cpRNFL) thickness, macular ganglion cell-inner plexiform layer (GCIPL) thickness, and glaucoma among lifetime never-smokers. Cross-sectional, nationwide population-based study. A total of 4,276 lifetime never-smokers (354 with SHS exposure and 3,922 without SHS exposure) from the Korea National Health and Nutrition Examination Survey 2019-2021. Self-reported SHS exposure at home or in the workplace was the primary exposure. cpRNFL and macular GCIPL thicknesses were measured using spectral-domain optical coherence tomography, and glaucoma was centrally adjudicated according to the International Society of Geographical and Epidemiological Ophthalmology criteria. Survey-weighted linear and logistic regression analyses were performed to investigate the associations of SHS exposure with cpRNFL thickness, macular GCIPL thickness, and glaucoma. Trends across the number of exposure settings were also evaluated. cpRNFL thickness, macular GCIPL thickness, and glaucoma. Compared with unexposed never-smokers, SHS-exposed participants were younger (47.0±13.1 vs. 49.0±14.0 years, standardized mean difference [SMD]=-0.144), had a greater intraocular pressure (15.1±2.3 vs. 14.9±2.3 mmHg, SMD=0.106), deeper anterior chamber (2.79±0.32 vs. 2.74±0.32 mm, SMD=0.155), and a thinner global cpRNFL (93.0±9.9 vs. 94.4±9.9 µm, SMD=-0.145), whereas axial length, macular GCIPL thickness, and glaucoma prevalence (4.4% vs. 3.4%, SMD=0.054) did not differ. After full adjustment, SHS exposure was associated with thinner global cpRNFL (β=-1.826, 95% confidence interval [CI]=-3.082 to -0.570, P=0.004), with a significant trend across the number of exposure settings (P for trend=0.003). In sectoral analyses, thinner cpRNFL was observed in the inferior (β=-3.003, P=0.006) and temporal (β=-1.429, P=0.012) sectors, which remained significant after Bonferroni correction. Exposed never-smokers had higher odds of belonging to the thinnest cpRNFL quartile (odds ratio=1.485, 95% CI=1.081 to 2.039, P=0.015). Average macular GCIPL thickness (P=0.617) and glaucoma (P=0.170) were not significantly associated with SHS exposure. SHS exposure was associated with cpRNFL thinning in lifetime never-smokers, but not with macular GCIPL thickness or glaucoma. These findings suggest a subclinical structural vulnerability of the cpRNFL to SHS exposure and underscore the public health imperative of reducing SHS exposure to protect ocular neuroaxonal health in never-smokers.
中文摘要:目的:探讨家庭和工作场所二手烟暴露与终身不吸烟者视盘周围视网膜神经纤维层厚度、黄斑神经节细胞内丛状层厚度及青光眼之间的关联。方法:这是一项基于全国人口的横断面研究。研究对象来自2019至2021年韩国国家健康与营养检查调查,共纳入4276名终身不吸烟者(其中354人有二手烟暴露史,3922人无暴露史)。主要暴露因素为自我报告的家庭或工作场所二手烟暴露情况。采用光谱域光学相干断层扫描测量视盘周围视网膜神经纤维层和黄斑神经节细胞内丛状层厚度,并依据国际地理与流行病学眼科学会标准对青光眼进行中央裁定。采用调查加权线性回归和逻辑回归分析探讨二手烟暴露与上述指标及青光眼的关联,并评估不同暴露环境数量下的趋势。结果:与未暴露的不吸烟者相比,二手烟暴露参与者更年轻(47.0±13.1岁 vs 49.0±14.0岁,标准化均数差=-0.144),眼压更高(15.1±2.3 mmHg vs 14.9±2.3 mmHg,SMD=0.106),前房更深(2.79±0.32 mm vs 2.74±0.32 mm,SMD=0.155),且全球视盘周围视网膜神经纤维层更薄(93.0±9.9 µm vs 94.4±9.9 µm,SMD=-0.145);而眼轴长度、黄斑神经节细胞内丛状层厚度及青光眼患病率(4.4% vs 3.4%,SMD=0.054)无显著差异。完全调整后的分析显示,二手烟暴露与全球视盘周围视网膜神经纤维层变薄相关(β=-1.826,95%置信区间=-3.082至-0.570,P=0.004),且在不同暴露环境数量间存在显著趋势(P for trend=0.003)。在扇区分析中,下方(β=-3.003,P=0.006)和颞侧(β=-1.429,P=0.012)扇区的视盘周围视网膜神经纤维层变薄显著,且在Bonferroni校正后仍保持显著。暴露组不吸烟者属于最薄视盘周围视网膜神经纤维层四分位数的几率更高(比值比=1.485,95%置信区间=1.081至2.039,P=0.015)。平均黄斑神经节细胞内丛状层厚度(P=0.617)和青光眼(P=0.170)与二手烟暴露无显著关联。结论:二手烟暴露与终身不吸烟者的视盘周围视网膜神经纤维层变薄相关,但与黄斑神经节细胞内丛状层厚度或青光眼无关。这些发现提示视盘周围视网膜神经纤维层对二手烟暴露存在亚临床的结构脆弱性,并强调了减少二手烟暴露以保护不吸烟者眼部神经轴突健康的重要性。
Ophthalmology IF 10.9 2026-11-14 PMID: 43033929
To identify patient characteristics associated with ocular hypertension after steroid use in children. Retrospective cohort study. Children ≤18 years of age seen at a tertiary care children's hospital between 2009 and 2025 who were prescribed any type of steroid and had a documented intraocular pressure (IOP) measurement within 1 to 60 days of steroid initiation. Children with any IOP measurement >21 mmHg recorded prior to or on the day of steroid initiation were excluded. Steroid type, route of administration, and patient characteristics, including comorbidities, were extracted from the electronic medical record. Univariable and multivariable logistic regression models were used to identify factors independently associated with ocular hypertension after steroid use. Ocular hypertension among children who underwent IOP measurement after steroid initiation, defined as IOP >21 mmHg measured within 1 to 60 days of steroid initiation. Of 5,687 children included (mean age at steroid initiation 8.8 years; 54.4% male), 1,034 (18.2%) developed ocular hypertension. The most frequently prescribed steroid was fluticasone (20.0%), and the most common route of administration was inhaled/intranasal (24.8%). In multivariable analysis, glaucoma conferred the highest odds of ocular hypertension after steroid use (adjusted odds ratio [aOR], 6.77; 95% CI, 5.21-8.79), followed by prednisone relative to dexamethasone (aOR, 3.37; 95% CI, 2.30-4.93), juvenile arthritis (aOR, 1.56; 95% CI, 1.09-2.24), and uveitis (aOR, 1.52; 95% CI, 1.16-1.99). Compared with topical administration, ocular (aOR, 3.57; 95% CI, 2.39-5.33) and intravenous (aOR, 2.63; 95% CI, 1.78-3.89) routes each independently conferred higher odds of ocular hypertension. Age, sex, race, ethnicity, diabetes, and asthma were not independently associated with ocular hypertension. Nearly 1 in 5 children with an IOP measurement within 1 to 60 days of steroid initiation developed ocular hypertension. Glaucoma, uveitis, juvenile arthritis, and non-topical routes of administration-particularly ocular and intravenous-were the strongest risk factors, highlighting the importance of ophthalmic monitoring in children receiving glucocorticoid therapy.
中文摘要:目的:识别与儿童使用糖皮质激素后发生眼压升高相关的患者特征。方法:本研究为回顾性队列研究。纳入2009年至2025年间在某三级儿童医院就诊且年龄小于等于18岁、处方了任何类型糖皮质激素并在激素起始使用后1至60天内有记录的眼内压(IOP)测量的儿童。排除在激素起始使用前或当天有任何眼内压测量值大于21 mmHg的儿童。从电子病历中提取激素类型、给药途径及患者特征,包括合并症。采用单变量和多变量逻辑回归模型识别与使用糖皮质激素后发生眼压升高独立相关的因素。结局指标:在激素起始使用后接受IOP测量的儿童中发生的眼压升高,定义为激素起始使用后1至60天内测量的眼内压大于21 mmHg。结果:纳入5,687名儿童(激素起始使用时平均年龄8.8岁;男性占54.4%),其中1,034人(18.2%)发生眼压升高。最常处方的是氟替卡松(20.0%),最常见的给药途径是吸入/鼻内(24.8%)。多变量分析显示,青光眼在使用糖皮质激素后导致眼压升高的几率最高(调整比值比[aOR]为6.77;95%置信区间[CI] 5.21-8.79),其次是泼尼松相对于地塞米松(aOR 3.37;95% CI 2.30-4.93)、幼年特发性关节炎(aOR 1.56;95% CI 1.09-2.24)和葡萄膜炎(aOR 1.52;95% CI 1.16-1.99)。与局部给药相比,眼内注射(aOR 3.57;95% CI 2.39-5.33)和静脉注射(aOR 2.63;95% CI 1.78-3.89)途径均独立地增加了眼压升高的几率。年龄、性别、种族、民族、糖尿病和哮喘与眼压升高无独立关联。结论:在激素起始使用后1至60天内有IOP测量的儿童中,近五分之一发生了眼压升高。青光眼、葡萄膜炎、幼年特发性关节炎以及非局部给药途径(尤其是眼内和静脉注射)是最强的危险因素,强调了接受糖皮质激素治疗的儿童进行眼科监测的重要性。

4影像与人工智能 (1篇)

基础研究 (1篇)

Medical image analysis IF 14.0 2026-11-16 PMID: 43057091
The segmentation of anatomical structures like corneal nerves and Langerhans cells in in vivo corneal confocal microscopy is vital for diagnosing many ocular and systemic diseases. While deep learning offers a promising path to automation, its clinical translation is hampered by domain shift and a scarcity of labeled data across multi-center cohorts. To address these limitations, we propose Semi-NC, a semi-supervised framework that learns domain-invariant representations from both labeled and unlabeled data through a synergistic, four-step cycle: (1) extracting multi-scale prototype features, (2) refining them via feature amplification regularization, (3) constructing and updating category-specific prototype pools by aggregating features, and (4) aligning pixels to prototypes via contrastive learning to optimize the feature space for precise segmentation. Extensive evaluations on seven datasets (10,987 images across 22 diseases) show that Semi-NC sets a new state-of-the-art, outperforming fully-supervised baselines with minimal labels. The framework also demonstrates strong generalization under in-distribution and out-of-distribution tests, along with a robust self-evolution capability that allows it to extend its functionality using unseen data while preserving performance on learned tasks. Its broad clinical utility is further validated by superior performance on retinal optical coherence tomography angiography. To support reproducibility, we will open-source the code and the first multi-center, multi-disease dataset with high-quality annotations at https://github.com/iMED-Lab/Semi-NC.
中文摘要:在体角膜共聚焦显微镜中角膜神经和朗格汉斯细胞等解剖结构的分割对于诊断多种眼病和系统性疾病至关重要。尽管深度学习为自动化提供了有前景的路径,但其临床转化受到域偏移以及多中心队列中标注数据稀缺的阻碍。为解决这些局限性,我们提出了Semi-NC半监督框架,该框架通过协同的四步循环从标注和无标注数据中学习域不变表示:首先提取多尺度原型特征,其次通过特征扩增正则化对其进行优化,然后通过聚合特征构建并更新类别特定的原型池,最后通过对比学习将像素与原型对齐以优化特征空间从而实现精确分割。在七个数据集(涵盖22种疾病的10987张图像)上的广泛评估表明,Semi-NC确立了新的最先进水平,在极少标注的情况下优于全监督基线。该框架在分布内和分布外测试中均表现出强大的泛化能力,并具备稳健的自我进化能力,使其能够在保持已学习任务性能的同时利用未见数据扩展功能。其在视网膜光学相干断层扫描血管造影上的优越性能进一步验证了其广泛的临床实用性。为支持可重复性,我们将开源代码以及首个具有高质量标注的多中心多疾病数据集,地址为https://github.com/iMED-Lab/Semi-NC

5白内障与屈光手术 (1篇)

基础研究 (1篇)

Advanced healthcare materials IF 11.0 2026-11-15 PMID: 43035409
Posterior capsule opacification (PCO) is the most frequent complication of cataract surgery and is driven by the epithelial-mesenchymal transition (EMT) of residual lens epithelial cells (LECs). The current standard of care, Nd:YAG laser capsulotomy, is reactive and carries well-documented complications, underscoring the need for proactive pharmacological prophylaxis. Drug-eluting intraocular lenses offer a localized delivery platform. Here, we developed a sulforaphane (SFN)-eluting intraocular lens (GelMA-SFN@IOL) by integrating SFN-loaded gelatin methacryloyl (GelMA) microparticles onto the IOL haptics. The GelMA carrier was designed to respond to MMP-2/9, which were upregulated in PCO-associated capsular tissues. In vitro, MMP-2 enhanced SFN release from GelMA-SFN microparticles, supporting enzyme-responsive release behavior. In TNFα-stimulated HLE-B3 cells, SFN suppressed LEC migration and EMT marker expression, accompanied by increased autophagic activity and reduced MMP-2/9 expression. These findings suggest a potential feedback mechanism whereby SFN-mediated MMP downregulation could reduce enzyme-promoted carrier degradation and release as the pathological signal subsides. In a rabbit PCO model, GelMA-SFN@IOL preserved capsular clarity and reduced aberrant LEC proliferation over 28 days, with no obvious histological abnormalities in the examined ocular tissues. Together, these results support a proof-of-concept strategy combining an enzyme-responsive carrier with an MMP-modulating therapeutic for early post-surgical PCO prevention, with potential for self-limiting release.
中文摘要:后发性白内障(PCO)是白内障手术最常见的并发症,由残留晶状体上皮细胞(LECs)的上皮-间质转化(EMT)驱动。当前的标准治疗Nd:YAG激光囊切开术属于反应性治疗且伴有已记录的并发症,凸显了对主动药物预防的需求。载药人工晶体提供了局部递送平台。本研究通过在人工晶体襻上整合负载萝卜硫素(SFN)的甲基丙烯酰化明胶(GelMA)微颗粒,开发了SFN缓释人工晶体(GelMA-SFN@IOL)。GelMA载体被设计为响应PCO相关囊膜组织中上调的MMP-2/9。体外实验中,MMP-2增强了SFN从GelMA-SFN微颗粒中的释放,支持了酶响应性释放行为。在TNFα刺激的HLE-B3细胞中,SFN抑制了LEC迁移和EMT标志物表达,伴随自噬活性增加和MMP-2/9表达降低。这些发现表明了一种潜在的反馈机制,即SFN介导的MMP下调可能在病理信号减弱时减少酶促载体降解和释放。在兔PCO模型中,GelMA-SFN@IOL在28天内保持了囊膜清晰度并减少了异常LEC增殖,检查的眼组织中没有明显的组织学异常。综上所述,这些结果支持了一种概念验证策略,即将酶响应性载体与MMP调节治疗相结合用于术后早期PCO预防,具有自我限制释放的潜力。

6角膜与眼表疾病 (1篇)

基础研究 (1篇)

Carbohydrate polymers IF 13.2 2026-11-15 PMID: 42907044
Plant protein nanoparticles represent promising oral carriers for hydrophobic bioactives in functional foods, yet their poor dispersibility and gastrointestinal instability limit delivery efficacy. In this study, maltodextrin (MD) was covalently conjugated with pumpkin seed protein (PP) through wet-heating glycation to construct a core-shell nanocarrier for oral pterostilbene (PTE) delivery, designated as PTE@P-M. The glycated MD-derived shell markedly improved PP solubility, reduced turbidity, and moderated surface hydrophobicity, indicating substantial remodeling of PP physicochemical properties. PTE@P-M exhibited an encapsulation efficiency of 94.47 ± 3.96% and a particle size of 249.3 ± 18.0 nm. Relative to PTE-loaded heat-treated PP (PTE@H-P), PTE@P-M retained more PTE under thermal, acidic, and Ca2+ stress conditions and demonstrated improved in vitro digestion behavior and release kinetics. Interaction analysis and molecular docking indicated that non-covalent interactions collectively contributed to PTE stabilization within the glycated matrix. In vivo, PTE@P-M increased oral bioavailability by 3.1-fold relative to free PTE and by 1.3-fold relative to PTE@H-P. The enhanced biological efficacy of PTE@P-M was further validated in a dry eye disease model, as evidenced by increased tear secretion and alleviated ocular surface damage. Collectively, Maillard-induced MD conjugation generated a protein-core/carbohydrate-shell nanoarchitecture that enhanced PTE stability, gastrointestinal performance, and oral bioavailability.
中文摘要:植物蛋白纳米颗粒作为功能性食品中疏水性生物活性物质的口服载体具有广阔前景,但其分散性差和胃肠道不稳定性限制了递送效率。本研究通过湿法加热糖基化反应将麦芽糊精(MD)与南瓜籽蛋白(PP)共价结合,构建了用于口服白藜芦醇(PTE)递送的核心-壳纳米载体,命名为PTE@P-M。糖基化的MD衍生物外壳显著提高了PP的溶解度,降低了浊度并调节了表面疏水性,表明PP的物理化学性质发生了实质性重塑。PTE@P-M的包封率为94.47±3.96%,粒径为249.3±18.0 nm。与负载PTE的热处理PP(PTE@H-P)相比,PTE@P-M在热、酸性和Ca2+应激条件下保留了更多的PTE,并表现出改善的体外消化行为和释放动力学。相互作用分析和分子对接表明,非共价相互作用共同促进了PTE在糖基化基质中的稳定。体内实验显示,与游离PTE相比,PTE@P-M使口服生物利用度提高了3.1倍,与PTE@H-P相比提高了1.3倍。PTE@P-M增强的生物学功效在干眼病模型中得到了进一步验证,表现为泪液分泌增加和眼表损伤减轻。综上所述,美拉德反应诱导的MD结合生成了蛋白质核心/碳水化合物壳纳米结构,增强了PTE的稳定性、胃肠道性能和口服生物利用度。